These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3306877)

  • 21. Use of citrulline as a diagnostic marker in the prospective treatment of urea cycle disorders.
    Batshaw ML; Berry GT
    J Pediatr; 1991 Jun; 118(6):914-7. PubMed ID: 2040929
    [No Abstract]   [Full Text] [Related]  

  • 22. Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis.
    Brusilow SW
    J Clin Invest; 1984 Dec; 74(6):2144-8. PubMed ID: 6511918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective treatment of urea cycle disorders.
    Maestri NE; Hauser ER; Bartholomew D; Brusilow SW
    J Pediatr; 1991 Dec; 119(6):923-8. PubMed ID: 1720458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperammonemia.
    Batshaw ML
    Curr Probl Pediatr; 1984 Nov; 14(11):1-69. PubMed ID: 6510017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periodic hyperammonemia, hyperlysinemia, and homocitrullinuria associated with decreased argininosuccinate synthetase and arginase activities.
    Sogawa H; Oyanagi K; Nakao T
    Pediatr Res; 1977 Sep; 11(9 Pt 1):949-53. PubMed ID: 904980
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: Ammonia disposal in Reye's syndrome.
    Smith AL
    N Engl J Med; 1976 Apr; 294(16):897-8. PubMed ID: 1250317
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion.
    Batshaw ML; Brusilow S; Waber L; Blom W; Brubakk AM; Burton BK; Cann HM; Kerr D; Mamunes P; Matalon R; Myerberg D; Schafer IA
    N Engl J Med; 1982 Jun; 306(23):1387-92. PubMed ID: 7078580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrasting features of urea cycle disorders in human patients and knockout mouse models.
    Deignan JL; Cederbaum SD; Grody WW
    Mol Genet Metab; 2008 Jan; 93(1):7-14. PubMed ID: 17933574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variation in the urea cycle: a model resource for investigating key candidate genes for common diseases.
    Mitchell S; Ellingson C; Coyne T; Hall L; Neill M; Christian N; Higham C; Dobrowolski SF; Tuchman M; Summar M;
    Hum Mutat; 2009 Jan; 30(1):56-60. PubMed ID: 18666241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. False positive alanine tolerance test results in heterozygote detection of urea cycle disorders.
    Batshaw ML; Naylor EW; Thomas GH
    J Pediatr; 1989 Oct; 115(4):595-8. PubMed ID: 2795354
    [No Abstract]   [Full Text] [Related]  

  • 31. Urea-cycle enzyme deficiencies and an increased nitrogen load producing hyperammonemia in Reye's syndrome.
    Snodgrass PJ; DeLong GR
    N Engl J Med; 1976 Apr; 294(16):855-60. PubMed ID: 1250313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.
    Brusilow SW; Danney M; Waber LJ; Batshaw M; Burton B; Levitsky L; Roth K; McKeethren C; Ward J
    N Engl J Med; 1984 Jun; 310(25):1630-4. PubMed ID: 6427608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma alpha-ketoglutarate in urea cycle enzymopathies and its role as a harbinger of hyperammonemic coma.
    Batshaw ML; Walser M; Brusilow SW
    Pediatr Res; 1980 Dec; 14(12):1316-9. PubMed ID: 7208146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The simulation of the urea cycle: correlation of effects due to inborn errors in the catalytic properties of the enzymes with clinical-biochemical observations.
    Kuchel PW; Roberts DV; Nichol LW
    Aust J Exp Biol Med Sci; 1977 Jun; 55(3):309-26. PubMed ID: 911283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of argininosuccinate synthetase in the regulation of urea synthesis in the rat and argininosuccinate synthetase-associated metabolic disorder in man.
    Saheki T; Tsuda M; Takada S; Kusumi K; Katsunuma T
    Adv Enzyme Regul; 1980; 18():221-38. PubMed ID: 7446299
    [No Abstract]   [Full Text] [Related]  

  • 36. Differentiation of transient hyperammonemia of the newborn and urea cycle enzyme defects by clinical presentation.
    Hudak ML; Jones MD; Brusilow SW
    J Pediatr; 1985 Nov; 107(5):712-9. PubMed ID: 4056969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation for the treatment of urea cycle disorders.
    Whitington PF; Alonso EM; Boyle JT; Molleston JP; Rosenthal P; Emond JC; Millis JM
    J Inherit Metab Dis; 1998; 21 Suppl 1():112-8. PubMed ID: 9686349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prenatal diagnosis of carbamyl phosphate synthetase deficiency by fetal liver biopsy].
    Murotsuki J; Uehara S; Okamura K; Yajima A; Kikuchi M; Oura T; Miyabayashi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Dec; 43(12):1613-6. PubMed ID: 1744457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient hyperammonemias in infants with and without organic acidemia.
    Nyhan WL; Rubio V; Jordá A; Grisolia S; Gutierez F; Canosa C
    Adv Exp Med Biol; 1982; 153():331-8. PubMed ID: 7164908
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative analysis of urinary pyroglutamic acid in patients with hyperammonemia.
    Nakanishi T; Shimizu A; Saiki K; Fujiwara F; Funahashi S; Hayashi A
    Clin Chim Acta; 1991 Mar; 197(3):249-55. PubMed ID: 2049866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.